Global Ototoxicity Survey conducted with Lancet Commission on Global Hearing Loss
Hello,
We are collaborating with The Lancet Commission on Global Hearing Loss to collect data on the utilization of ototoxic medications (aminoglycoside and chemotherapy agents) and referral/care pathways for ototoxicity management in a variety of global healthcare settings. We will use these data to inform current research efforts to improve understanding of the global risk and caseload of ototoxic hearing loss. We are seeking survey respondents who practice primarily in low- and middle-income countries or other resource-limited settings.
As an organization that works with health professionals in the field of ENT/otolaryngology, we are asking for your assistance in distributing this short, 5 to 10-minute survey to members of your organization. The survey link is here: https://www.surveymonkey.com/r/9SKY6GS
We kindly ask that survey respondents complete the survey by September 18, 2023. Any survey respondents can also contact Dr Lauren Dillard (dillalau@musc.edu) with questions pertaining to the survey.
We appreciate your engagement in this effort.
Kind regards,
Dr Lauren Dillard and Dr James Saunders
Lauren Dillard, PhD, AuD/CCC-A, MS
Postdoctoral Fellow
Department of Otolaryngology – Head & Neck Surgery
Medical University of South Carolina
James E. Saunders, MD
Professor of Otology / Neurotology
Geisel School of Medicine at Dartmouth
Co-Chair Coalition for Global Hearing Health
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
james.e.saunders@hitchcock.org
0 Yorumlar